Cleared Traditional

K011710 - OXOID PBP2 1 LATEX AGGLUTINATION TEST
(FDA 510(k) Clearance)

Apr 2002
Decision
302d
Days
Class 2
Risk

K011710 is an FDA 510(k) clearance for the OXOID PBP2 1 LATEX AGGLUTINATION TEST. This device is classified as a System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies (Class II - Special Controls, product code MYI).

Submitted by Oxoid , Ltd. (Basingstoke, GB). The FDA issued a Cleared decision on April 2, 2002, 302 days after receiving the submission on June 4, 2001.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1640.

Submission Details

510(k) Number K011710 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2001
Decision Date April 02, 2002
Days to Decision 302 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code MYI — System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1640

Similar Devices — MYI System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies

All 9
MECA XPRESSFISH
K140619 · Advandx, Inc. · Oct 2014
ALERE PBP2A SA/CONS CULTURE COLONY TEST
K133851 · Alere Scarborough, Inc. · Sep 2014
ALERE PBP2A TEST
K121905 · Alere Scarborough, Inc. · Jul 2012
BINAXNOW PBP2A TEST, MODEL 890-000
K090301 · Binax, Inc. · Apr 2010
CLEARVIEW EXACT PBP2A TEST, MODEL 891-000
K091766 · Binax, Inc. · Feb 2010
MASTALEX -MRSA, MODEL RST501
K062864 · Mast Group , Ltd. · Oct 2006